Brief: Endonovo To Sell SofPulse Brand Business And IP To SofPulse Inc For A Minimum Of $50 Million
04/12/2023 15:05
Dec 4 (Reuters) - Endonovo Therapeutics Inc ENDV.PK :
* ENDONOVO SIGNS DEFINITIVE AGREEMENT TO SELL SOFPULSE®
BRAND
BUSINESS AND IP TO SOFPULSE INC. FOR A MINIMUM OF $50 MILLION
Source text for Eikon: ID:nGNXb86rV
Further company coverage: ENDV.PK
((reuters.briefs@thomsonreuters.com;))
Recent news on Endonovo Therapeutics
See all newsBrief: Endonovo To Sell SofPulse Brand Business And IP To SofPulse Inc For A Minimum Of $50 Million
Brief: Endonovo’S Sofpulse® Nears Final Stages To Receive Taiwan FDA License To Distribute In Taiwan
Brief: Endonovo Therapeutics Inc - Sofpulse, Inc. Will Operate Independently After Planned Spin-Off
Brief: Endonovo Therapeutics Details Plan To Spin Off Medical Device Division As A Listed Public Company
Brief: Endonovo Announces Plan To Explore Strategic Alternatives For Its Sofpulse Medical Device Assets